Screening the incidence of diabetogensis with urinary phthalate in Saudi subjects

Nowadays, phthalates widely employed in many products are distributed around us which contributed to the development of many chronic diseases. We investigated the incidence of type 2 diabetes mellitus (T2DM) in Saudi subjects and correlated it with urinary phthalate metabolites' screening study. We selected a total of 100 cases early diagnosed as type 2 diabetes mellitus (FBS >= 126 mg/dl, PP 2 h, >= 140 mg/dl) and 50 normal subjects (FBS <= 90 mg/dl) as control. Overnight fasting blood samples were subjected for assay of FBS, glycated hemoglobin, insulin, C-peptide, HOMA-IR, advanced glycation end products (AGEs), and urinary assay of some phthalate metabolite levels. Data obtained showed a significant elevation of FBS, HA1c, AGEs, insulin, and C-peptide and HOMA-IR in diabetic patients compared with the control (p < 0.001). Urinary phthalate metabolites such as mono-ethyl phthalate (mEP), mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP), and mono-n-butyl phthalate (mBP) were detected in significant concentrations in diabetic patients compared with control. A positive correlation was found between mEP and mBP and HOMA-IR and C-peptide. Phthalate toxicity is considered as one of the risk factors that contributed to insulin resistance and development of T2DM via increasing the levels of HOMA-IR and C-peptide.This will result in the risk of phthalate exposure for diabetogensis and its economic cost for treatment lifetime.

Automated summary

This study investigated the incidence of type 2 diabetes mellitus in Saudi subjects and found significant concentrations of urinary phthalate metabolites in diabetic patients. Additionally, the study suggests that phthalate toxicity may contribute to insulin resistance and the development of type 2 diabetes mellitus.